Intrinsiqs

Is Rapport Therapeutics, Inc. Common Stock overvalued?

Rapport Therapeutics, Inc. Common Stock (RAPP) — key valuation metrics and fundamentals.

No verdict
Price
$42.31
Fair value
Current P/E
Normal P/E
Market cap
$1.48B
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares RAPP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.